Single strep bacteria protein sets off white blood cell's early warning system

August 7, 2017
This is an electronic microscopy image of Group A Streptococcus (faint purple chains) overlaid with a confocal microscopy image of M protein (red) internalized in macrophages (blue). Credit: UC San Diego Health

Group A Streptococcus bacteria—the cause of strep throat and flesh-eating infections—have been well studied for nearly a century. But researchers at University of California San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences recently made a surprising discovery: strep's M protein alone wipes out macrophages, but not other types of immune cells. The macrophages' self-sacrifice serves as an early warning of infection to the rest of the immune system.

The study, published August 7 in Nature Microbiology, revealed new roles for the well-studied M protein and for . The researchers said this new information should inform current vaccine strategies, many of which are based on M protein, and new treatment approaches for invasive infections and toxic shock syndrome, where hyper-immune responses can be detrimental.

M protein, an abundant, tentacle-like molecule that projects from the bacterium's surface, is strep's most important virulence factor. M protein is known to help the bacteria adhere to human tissues, make it harder for to engulf the bacteria, and bind or inhibit other components of the human immune system, such as antibodies and antimicrobial peptides.

"We thought we already knew pretty much everything there was to know about how M protein helps strep gain a foothold in the human body and avoid the immune system, so this was a totally unexpected discovery, and an especially dramatic thing for an immune cell to do," said Victor Nizet, MD, professor of pediatrics and pharmacy, who led the study with Partho Ghosh, PhD, professor of chemistry and biochemistry at UC San Diego.

After noticing that macrophages in a laboratory dish quickly died after M protein exposure, the researchers wanted to determine why—and why it happens only macrophages. They found that macrophages recognize strep bacteria and respond by activating genes that encode IL-1beta, a pro-inflammatory signaling molecule, and components of NLRP3, cellular machinery that manages inflammation. At the same time, these macrophages also gobble up M proteins freed from the bacterial cell surface, triggering a second signal required for NLRP3 activation.

As a result, macrophages quickly release IL-1beta as a warning signal to other parts of the immune system, but at a cost to themselves: They commit cellular suicide in the process, further escalating the inflammatory response. Inflammation is good when fighting an infection, but too much can lead to a number of health problems.

"So you can see this as a beneficial system for infection, like Paul Revere riding out with a lantern to warn that the British are coming," Nizet said. "The problem is that if a million people—or a million macrophages—light lanterns all at once and hay catches fire, then you're in trouble."

Here's how that played out in living systems: While macrophages in a laboratory dish infected with live normal spew IL-1beta and then commit suicide, strep engineered to lack M protein do not have the same effect. Likewise, mice administered with purified M protein alone produced significantly more IL-1beta than mice that received a control. The more M protein they received, the more IL-1beta they generated.

According to Nizet, these findings underscore the significant role strep and M protein have played in human history—important enough that the human immune system has evolved a rapid response system just for them.

J. Andrés Valderrama, PhD, a postdoctoral researcher in Nizet's research group and first author of the study, described the future of this work.

"Our study suggests that targeting M proteins with vaccines or antibodies or blocking the way macrophages bring it into the cell might prove clinically useful in cases where hyper-inflammation has become a problem, such as in an invasive infection or toxic shock syndrome," he said. "But it's a delicate balance—we don't want to block the early warning signal altogether or the immune system would lose its first line of defense against strep."

M protein is under active consideration as a vaccine antigen. The challenge is that human antibodies generated against M protein can cross-react with host tissue, leading to rheumatic fever, an autoimmune disease. UC San Diego and other researchers are looking for workarounds and ways to engineer out the immunogenic parts of the M protein.

In the meantime, Nizet and Valderrama are also working to better understand how M proteins and macrophages interact. To that end, they've created a library of macrophage variants, each with a different gene mutated using the gene editing technique CRISPR-Cas9. They'll test each variant to find those that are resistant to M -induced suicide. Their findings may surface more molecular players in this early warning system and thus provide more therapeutic targets for invasive strep infections and .

Their quest is urgent: Group A strep is responsible for more than 700 million infections worldwide each year, with an estimated 663,000 cases of invasive disease and 163,000 deaths.

Explore further: Flesh-eating infections in rheumatoid arthritis patients spur new discovery

More information: J. Andrés Valderrama et al, Group A streptococcal M protein activates the NLRP3 inflammasome, Nature Microbiology (2017). DOI: 10.1038/s41564-017-0005-6

Related Stories

Flesh-eating infections in rheumatoid arthritis patients spur new discovery

August 19, 2016
Rheumatoid arthritis patients taking medications that inhibit interleukin-1beta (IL-1beta), a molecule that stimulates the immune system, are 300 times more likely to experience invasive Group A Streptococcal infections than ...

Biochemists' discovery could lead to vaccine against 'flesh-eating' bacteria

September 5, 2016
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria—responsible for ...

A key step toward a safer strep vaccine

June 11, 2014
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, have identified the genes encoding a molecule that famously defines Group A Streptococcus (strep), a pathogenic ...

Recommended for you

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

December 9, 2017
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening ...

Location, location, location: Immunization delivery site matters

December 1, 2017
In vaccination, a certain subpopulation of dendritic cells is vital to triggering the body's adaptive immune system, report researchers at The Jackson Laboratory (JAX), Yale University and Astra-Zeneca.

An anti-aging protein could be targeted to rejuvenate immune cells

November 30, 2017
Anti-aging proteins have long been shown to protect against age-related diseases, such as cancer, neurodegeneration, and cardiovascular disease. A study by researchers at the Gladstone Institutes now reveals that one such ...

Scientists find key to miscarriages in blood clotting disorder

November 28, 2017
Monash University researchers have potentially shed light on why women with the rare autoimmune disorder Antiphospholipid syndrome (APS) are prone to successive pregnancy losses.

How do cells release IL-1? After three decades, now we know

November 28, 2017
Researchers at Boston Children's Hospital have identified, for the first time, the molecule that enables immune cells to release interleukin-1 (IL-1), a key part of our innate immune response to infections. Findings were ...

Why do more women have asthma than men? Blame hormones

November 28, 2017
Women are twice as likely as men to have asthma, and this gender difference may be caused by the effects of sex hormones on lung cells. Researchers at Vanderbilt University and Johns Hopkins found that testosterone hindered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.